Bringing the fundamentals into focus…
Back to Pharming Group N.V.
How Pharming Group N.V. stacks up
PHAR · against 1,336 other Healthcare companies
Valuation
42/ 100
Below the middle of the pack.
Ranked #770 of 1,337 · scores higher than 42% of peers
Bars: peers in each 10-point band of the valuation score134 peers with a valuation score of 40–49, including PHAR · Click a bar to see the companies
Why valuation scores 42?
Weighted metrics compared with all Healthcare companies.Its metrics sit close to the Healthcare norm.
- Earnings yield is close to the peer norm. Earnings yield: 0.2% vs peer median 1.5%
- EBITDA yield is close to the peer norm. EBITDA yield: 3.8% vs peer median 4.0%
- more free cash flow for the price paid: stronger than 72% of peers. Free cash flow yield: 2.9% vs peer median 0.0%
Metric by metric
Position: dot = PHAR, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | PHAR | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | 1.1% | 1.5% | 47% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | 3.8% | 4.2% | 48% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | 3.8% | -1.0% | 72% | 20% | |
| Book yieldHigher is better · 1,306 reported | 29.5% | 37.9% | 40% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around PHAR| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 770 | 56.7B USD | 42 | 79 | |
| 770 | 1.1B NOK (≈$105M) | 42 | 58 | |
| 770 | 5.1B USD | 42 | 52 | |
| 770 | 1.1B USD | 42 | 31 | |
| 770 | 915M USD | 42 | 57 | |
| 770 | 2.7B USD | 42 | 56 | |
| 770 | 5.8B USD | 42 | 38 | |
| 770 | 303.5B INR (≈$3.6B) | 42 | 47 | |
| 783 | 64.1B CNY (≈$9.0B) | 41 | 48 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score